Job Market Monitor
Pharmaceutical
Royal DSM – To cut as many as 1100 jobs by 2017
Royal DSM will make up to 1100 staff redundant by the end of 2017 in a reorganisation designed to cut the cost of running its pharma, nutrition and materials sciences businesses. The Dutch supplier announced the planned job cuts today, explaining that the move is designed to save it €125m to €150m ($144m to $173m) … Continue reading
Novartis – Up to 3,000 job cuts in just 4 months
Unlike every other Big Pharma company in the world, Novartis ($NVS) tends to prefer to communicate rather selectively when it chops a facility here or winnows out its ranks over there in its global structure. Specifics on the secretive Basel-based company tend to leak out through local reports, if at all, with releases targeted at … Continue reading
Bristol-Myers in France / Threatening to cut jobs at its two Agen factories
Bristol-Myers Squibb, BMY -0.76% the New York-based drug maker, is threatening to cut jobs at its two Agen factories, where a range of paracetamol painkillers are made, after the French government unveiled plans to push for wider use of cheaper generic versions. The government may announce its final decision as early as Thursday, according to … Continue reading
Novartis / To cut or transfer up to 4,000 jobs
Novartis has confimred that pharma jobs will be reallocated in 2014 in a continuation of the productivity drive that saved the firm $2.8bn (EUR2bn) last year. Swiss newspaper NZZ am Sonntag reported that Novartis was looking to cut or transfer up to 4,000 jobs – approximately 6% of its global workforce – earlier this week. … Continue reading
AstraZeneca in India / To close R&D unit with more than 150 jobs cut
British drug-maker AstraZeneca said it will close its research and development unit in Bangalore, India, making more than 150 jobs redundant. The move, as part of an ongoing global restructuring exercise, will also shut down its early stage research on tropical diseases tuberculosis and malaria. The existing research will be moved to its UK facility … Continue reading
Layoffs in Pharmaceuticals / The top 10 largest in 2013
The patent cliff is often the big culprit. One might think that a one-to-one relationship could be graphed between what is happening with the patent cliff and layoffs, but that is not the case Continue reading
Novartis / To shuffle and cut jobs
Swiss drugmaker Novartis plans to reorganise parts of its domestic workforce, cutting up to 500 jobs in its pharmaceutical division to free resources for new roles to support the product launches, the company said on Tuesday. The redeployment comes as new chairman Joerg Reinhardt casts a fresh eye over the company’s operations as part of … Continue reading
Pharmaceutical / The Skills Gap
It is no secret that there is a shortage of professional skill sets in the life sciences and pharmaceutical sector, and nowhere is this more keenly felt than in the area of Biostatistics where experienced professionals are in demand all across Europe Continue reading
Novartis / To Cut 500 Jobs
Novartis AG (NOVN) plans to close two sites in Europe, move staff from California to the Boston area and cut about 500 jobs in an effort consolidate its research operations, especially in respiratory diseases. Novartis plans to close sites in Horsham, England, and Vienna and move cancer research from Emeryville, California, to Cambridge, Massachusetts, Eric … Continue reading
Jobs – Offres d’emploi – US & Canada (Eng. & Fr.)
The Most Popular Job Search Tools
Even More Objectives Statements to customize
Cover Letters – Tools, Tips and Free Cover Letter Templates for Microsoft Office
Job Market Monitor 